Zymergen has named Jay Flatley as the Chairman of the Board of Directors, effective immediately. Jay has served as lead Independent Director on Zymergen's board since late 2019. Beyond his role as Chairman of Zymergen's Board, Mr. Flatley will continue as Chairman of the Board of Directors at Illumina through May 26, 2021, where he previously served as CEO from 1999 until 2016. In addition to his work at Illumina, he serves on the Board of Directors at Coherent and Denali, is Chairman of the Board at Iridia and the Wellcome Trust Leap Fund, and is on the Board of Trustees for The Salk Institute.